Shareholders approve Ventrus/Assembly merger

Ventrus Biosciences (NASDAQ:VTUS) shareholders approve the issuance of common stock for the merger with Assembly Pharmaceuticals. The transaction was effective at 5 pm on July 11, 2014. Ventrus shareholders also approved a 1-for-5 reverse stock split and the change of corporate name to Assembly Biosciences. It will begin trading under the symbol "ASMB" today.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs